[ATHA] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ATHA] Athira Pharma, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -11.40%
YoY- -102.95%
Quarter Report
ATHA's Result
ATHA's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 0 0 0 0 0 -
PBT -32,970 -20,189 -15,674 -8,456 -1,530 115.34%
Tax -244 -3,944 2,153 -1 -103 24.04%
NP -32,970 -16,245 -15,674 -8,456 -1,530 115.34%
Tax Rate - - - - - -
Total Cost 32,970 16,245 15,674 8,456 1,530 115.34%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -0.87 -0.43 -0.42 -1.12 -0.18 48.23%
EPS Diluted -0.87 -0.43 -0.42 -1.12 -0.18 48.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.